Cover Image
市場調查報告書

骨質疏鬆症的全球市場:患者數、企業、預測

Global Osteoporosis Market, Patients, Companies & Forecast

出版商 Renub Research 商品編碼 210160
出版日期 內容資訊 英文 124 Pages; 89 Figures; 8 Tables
商品交期: 最快1-2個工作天內
價格
Back to Top
骨質疏鬆症的全球市場:患者數、企業、預測 Global Osteoporosis Market, Patients, Companies & Forecast
出版日期: 2015年09月24日 內容資訊: 英文 124 Pages; 89 Figures; 8 Tables
簡介

骨質疏鬆症,是無症狀疾病。預計全球骨質疏鬆症市場,到2019年規模擴大到400億美元。全球骨質疏鬆症患者,中國與印度,佔近80%。

本報告提供全球骨質疏鬆症市場相關調查分析,以市場現狀與今後五年的預測為焦點,提供骨質疏鬆症/髖關節骨折的患者數與預測、骨質疏鬆症市場與預測、各國認識層級/指南/政策、各國藥物的償付、各企業的銷售額與預測相關的系統性資訊。

第1章 摘要整理

第2章 全球骨質疏鬆症市場:患者人口分析

  • 骨質疏鬆症
  • 髖關節骨折

第3章 全球骨質疏鬆症市場

第4章 全球骨質疏鬆症市場:佔有率分析

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場佔有率
  • 製藥公司市場佔有率

第5章 印度

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 認識層級
  • 骨折登記
  • 政府的政策
  • 指南
  • 藥物的償付

第6章 中國

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 認識層級
  • 骨折登記
  • 政府的政策
  • 指南
  • 藥物的償付

第7章 日本

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 認識層級
  • 骨折登記
  • 政府的政策
  • 指南
  • 藥物的償付

第8章 韓國

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 認識層級
  • 骨折登記
  • 政府的政策
  • 指南
  • 藥物的償付

第9章 巴西

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 認識層級
  • 指南、政策
  • 償付政策

第10章 俄羅斯

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 認識層級
  • 政府的政策
  • 指南
  • 償付

第11章 英國

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 指南
  • 償付政策

第12章 法國

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 指南
  • 償付政策

第13章 德國

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 指南
  • 償付政策

第14章 美國

  • 骨質疏鬆症
  • 髖關節骨折
  • 市場
  • 政策
  • 指南
  • 償付政策

第15章 成長推動因素

第16章 課題

第17章 主要企業:骨質疏鬆症治療藥的銷售額與預測

  • Merck
  • Sanofi
  • Novartis
  • Eli Lilly
  • Amgen

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.

This is the 2nd edition report on Osteoporosis by Renub Research. Report titled "Global Osteoporosis Market, Patients, Companies & Forecast" provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market from 6 view points:

  • 1) Osteoporosis Patients & Forecast
  • 2) Hip fracture Patients & Forecast
  • 3) Osteoporosis Market & Forecast
  • 4) Country Wise Osteoporosis level of Awareness, Guidelines & Policy
  • 5) Country Wise Reimbursement of Medication
  • 6) Company Wise Osteoporosis Drugs Sales & Forecast

All the 10 Countries studied in the report are as follows

  • 1) India
  • 2) China
  • 3) Japan
  • 4) Korea
  • 5) Brazil
  • 6) Russia
  • 7) United Kingdom
  • 8) France
  • 9) Germany
  • 10) United States

Worldwide Osteoporosis - Company Wise Drugs Sales Analysis (2010 - 2019)

  • 1) Merck
  • 2) Sanofi
  • 3) Novartis
  • 4) Eli Lilly
  • 5) Amgen

Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephonic interviews with industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. Worldwide Osteoporosis Patients Population Analysis

  • 2.1 Worldwide Osteoporosis Patients Population (2010 - 2019)
  • 2.2 Worldwide Hip Fracture Patients Population (2010 - 2019)

3. Worldwide Osteoporosis Market (2010 - 2019)

4. Worldwide Osteoporosis Share Analysis

  • 4.1 Worldwide Osteoporosis Patients Population Share (2010 - 2019)
  • 4.2 Worldwide Hip Fracture Patients Population Share (2010 - 2019)
  • 4.3 Worldwide Osteoporosis Market Share (2010 - 2019)
  • 4.4 Worldwide Osteoporosis Drugs Company Market Share (2010 - 2019)

5. India

  • 5.1 India Osteoporosis Patients Population (2010 - 2019)
  • 5.2 India Hip Fracture Patients Population (2010 - 2019)
  • 5.3 India Osteoporosis Market (2010 - 2019)
  • 5.4 Level of Awareness
  • 5.5 Fracture Registries
  • 5.6 Government Policies
  • 5.7 Guidelines
  • 5.8 Reimbursement of Medication

6. China

  • 6.1 China Osteoporosis Patients Population (2010 - 2019)
  • 6.2 China Hip Fracture Patients Population (2010 - 2019)
  • 6.3 China Osteoporosis Market (2010 - 2019)
  • 6.4 Level of Awareness
  • 6.5 Fracture Registries
  • 6.6 Government Policies
  • 6.7 Guidelines
  • 6.8 Reimbursement of Medication

7. Japan

  • 7.1 Japan Osteoporosis Patients Population (2010 - 2019)
  • 7.2 Japan Hip Fracture Patients Population (2010 - 2019)
  • 7.3 Japan Osteoporosis Market (2010 - 2019)
  • 7.4 Level of Awareness
  • 7.5 Fracture Registries
  • 7.6 Government Policies
  • 7.7 Guidelines
  • 7.8 Reimbursement of Medication

8. Korea

  • 8.1 Korea Osteoporosis Patients Population (2010 - 2019)
  • 8.2 Korea Hip Fracture Patients Population (2010 - 2019)
  • 8.3 Korea Osteoporosis Market (2010 - 2019)
  • 8.4 Level of Awareness
  • 8.5 Fracture Registries
  • 8.6 Government Policies
  • 8.7 Guidelines
  • 8.8 Reimbursement of Medication

9. Brazil

  • 9.1 Brazil Osteoporosis Patients Population (2010 - 2019)
  • 9.2 Brazil Hip Fracture Patients Population (2010 - 2019)
  • 9.3 Brazil Osteoporosis Market (2010 - 2019)
  • 9.4 Level of Awareness
  • 9.5 Guidelines & Policy
  • 9.6 Reimbursement Policy

10. Russia

  • 10.1 Russia Osteoporosis Patients Population (2010 - 2019)
  • 10.2 Russia Hip Fracture Patients Population (2010 - 2019)
  • 10.3 Russia Osteoporosis Market (2010 - 2019)
  • 10.4 Level of Awareness
  • 10.5 Government Policy
  • 10.6 Guidelines
  • 10.7 Reimbursement

11. United Kingdom

  • 11.1 United Kingdom Osteoporosis Patients Population (2010 - 2019)
  • 11.2 United Kingdom Hip Fracture Patients Population (2010 - 2019)
  • 11.3 United Kingdom Osteoporosis Market (2010 - 2019)
  • 11.4 Guidelines
  • 11.5 Reimbursement Policy

12. France

  • 12.1 France Osteoporosis Patients Population (2010 - 2019)
  • 12.2 France Hip Fracture Patients Population (2010 - 2019)
  • 12.3 France Osteoporosis Market (2010 - 2019)
  • 12.4 Guidelines
  • 12.5 Reimbursement Policy

13. Germany

  • 13.1 Germany Osteoporosis Patients Population (2010 - 2019)
  • 13.2 Germany Hip Fracture Patients Population (2010 - 2019)
  • 13.3 Germany Osteoporosis Market (2010 - 2019)
  • 13.4 Guidelines
  • 13.5 Reimbursement Policy

14. United States

  • 14.1 United States Osteoporosis Patients Population (2010 - 2019)
  • 14.2 United States Hip Fracture Patients Population (2010 - 2019)
  • 14.3 United States Osteoporosis Market (2010 - 2019)
  • 14.4 Policy
  • 14.5 Guidelines
  • 14.6 Reimbursement Policy

15. Growth Driver

  • 15.1 Widespread Vitamin D Deficiency & Low Calcium Intake
  • 15.2 Globally Increasing Ageing Population & Life Expectancy

16. Challenges

  • 16.1 Lack of Reimbursement / Other Restrictions for Reimbursement
  • 16.2 Limited Access of Diagnostic Tools & Low Levels of Public and Health Professional Awareness
  • 16.3 Lack of Government Osteoporosis Policy, Guidelines & National Health Priority in Asia Pacific Countries

17. Key Players Osteoporosis Drugs Sales & Forecast

  • 17.1 Merck Osteoporosis Drugs Sales (2010 - 2019)
  • 17.2 Sanofi Osteoporosis Drugs Sales (2010 - 2019)
  • 17.3 Novartis Osteoporosis Drugs Sales (2010 - 2019)
  • 17.4 Eli Lilly Osteoporosis Drugs Sales (2010 - 2019)
  • 17.5 Amgen Osteoporosis Drugs Sales (2010 - 2019)

List of Figures

  • Figure 2-1: Worldwide - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 2-2: Worldwide - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 2-3: Worldwide - Distribution of Hip Fracture Risk in Men, 2012
  • Figure 2-4: Worldwide - Distribution of Hip Fracture Risk in Women, 2012
  • Figure 2-5: Worldwide - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 2-6: Worldwide - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 3-1: Worldwide - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 3-2: Worldwide - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 4-1: Worldwide - Osteoporosis Patients Population Share (Percent), 2010 - 2014
  • Figure 4-2: Worldwide - Forecast for Osteoporosis Patients Population Share (Percent), 2015 - 2019
  • Figure 4-3: Worldwide - Hip Fracture Patients Population Share (Percent), 2010 - 2014
  • Figure 4-4: Worldwide - Forecast for Hip Fracture Patients Population Share (Percent), 2015 - 2019
  • Figure 4-5: Worldwide - Osteoporosis Market Share (Percent), 2010 - 2014
  • Figure 4-6: Worldwide - Forecast for Osteoporosis Market Share (Percent), 2015 - 2019
  • Figure 4-7: Worldwide - Osteoporosis Drugs Company Market Share (Percent), 2010 - 2014
  • Figure 4-8: Worldwide - Forecast for Osteoporosis Drugs Company Market Share (Percent), 2015 - 2019
  • Figure 5-1: India - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 5-2: India - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 5-3: India - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 5-4: India - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 5-5: India - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 5-6: India - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 6-1: China - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 6-2: China - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 6-3: China - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 6-4: China - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 6-5: China - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 6-6: China - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 7-1: Japan - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 7-2: Japan - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 7-3: Japan - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 7-4: Japan - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 7-5: Japan - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 7-6: Japan - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 8-1: Korea - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 8-2: Korea - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 8-3: Korea - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 8-4: Korea - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 8-5: Korea - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 8-6: Korea - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 9-1: Brazil - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 9-2: Brazil - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 9-3: Brazil - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 9-4: Brazil - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 9-5: Brazil - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 9-6: Brazil - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 10-1: Russia - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 10-2: Russia - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 10-3: Russia - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 10-4: Russia - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 10-5: Russia - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 10-6: Russia - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 10-7: Russia - Level of Awareness (Percent), 2010
  • Figure 11-1: United Kingdom - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 11-2: United Kingdom - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019.
  • Figure 11-3: United Kingdom - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 11-4: United Kingdom - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 11-5: United Kingdom - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 11-6: United Kingdom - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 12-1: France - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 12-2: France - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 12-3: France - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 12-4: France - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 12-5: France - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 12-6: France - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 13-1: Germany - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 13-2: Germany - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 13-3: Germany - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 13-4: Germany - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 13-5: Germany - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 13-6: Germany - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 14-1: United States - Osteoporosis Patients Population (Thousand), 2010 - 2014
  • Figure 14-2: United States - Forecast for Osteoporosis Patients Population (Thousand), 2015 - 2019
  • Figure 14-3: United States - Hip Fracture Patients Population (Thousand), 2010 - 2014
  • Figure 14-4: United States - Forecast for Hip Fracture Patients Population (Thousand), 2015 - 2019
  • Figure 14-5: United States - Osteoporosis Market (Million US$), 2010 - 2014
  • Figure 14-6: United States - Forecast for Osteoporosis Market (Million US$), 2015 - 2019
  • Figure 15-1: Worldwide - Ageing Population & Forecast (Million), 2010 - 2050
  • Figure 15-2: Worldwide - Life Expectancy (Year), 1990, 2000 & 2012
  • Figure 17-1: Merck - Osteoporosis Drugs Sales (Million US$), 2010 - 2014
  • Figure 17-2: Merck - Forecast for Osteoporosis Drugs Sales (Million US$), 2015 - 2019
  • Figure 17-3: Sanofi - Osteoporosis Drugs Sales (Million US$), 2010 - 2014
  • Figure 17-4: Sanofi - Forecast for Osteoporosis Drugs Sales (Million US$), 2015 - 2019
  • Figure 17-5: Novartis - Osteoporosis Drugs Sales (Million US$), 2010 - 2014
  • Figure 17-6: Novartis - Forecast for Osteoporosis Drugs Sales (Million US$), 2015 - 2019
  • Figure 17-7: Eli Lilly - Osteoporosis Drugs Sales (Million US$), 2010 - 2014
  • Figure 17-8: Eli Lilly - Forecast for Osteoporosis Drugs Sales (Million US$), 2015 - 2019
  • Figure 17-9: Amgen - Osteoporosis Drugs Sales (Million US$), 2010 - 2014
  • Figure 17-10: Amgen - Forecast for Osteoporosis Drugs Sales (Million US$), 2015 - 2019

List of Tables

  • Table 5-1: India - Osteoporosis Treatments & Respective Reimbursement Status, 2013
  • Table 6-1: China - Osteoporosis Treatments & Respective Reimbursement Status, 2013
  • Table 7-1: Japan - Osteoporosis Treatments & Respective Reimbursement, 2013
  • Table 8-1: Korea - Osteoporosis Treatments & Respective Reimbursement, 2013
  • Table 11-1: United Kingdom - Available Medical Interventions & Reimbursement Policies, 2013
  • Table 12-1: France - Available Medical Interventions & Reimbursement Policies, 2013
  • Table 13-1: Germany - Available Medical Interventions & Reimbursement Policies, 2013
  • Table 16-1: Asia Pacific - Status of Osteoporosis in NHP & Guidelines Availability, 2013
Back to Top